T&L Co. Ltd (340570) - Cash Flow Conversion Efficiency
Based on the latest financial reports, T&L Co. Ltd (340570) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩9.68 Billion ≈ $6.56 Million USD) by net assets (₩199.09 Billion ≈ $134.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see T&L Co. Ltd stock valuation for the company's overall valuation and market capitalisation.
T&L Co. Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how T&L Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
T&L Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of T&L Co. Ltd ranked by their cash flow conversion efficiency. Explore 340570 cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mycenax Biotech
TWO:4726
|
-0.031x |
|
Alicanto Minerals Ltd
AU:AQI
|
-0.078x |
|
Paxman AB
ST:PAX
|
-0.014x |
|
Maple Gold Mines Ltd
V:MGM
|
-0.344x |
|
i-SENS Inc
KQ:099190
|
-0.004x |
|
Hope Education Group Co. Ltd
F:HE1
|
0.049x |
|
Wanhwa Enterprise Co
TW:2701
|
0.006x |
|
Seoul City Gas
KO:017390
|
-0.022x |
Annual Cash Flow Conversion Efficiency for T&L Co. Ltd (2018–2024)
The table below shows the annual cash flow conversion efficiency of T&L Co. Ltd from 2018 to 2024. View today's stock price for T&L Co. Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩171.44 Billion ≈ $116.18 Million |
₩46.57 Billion ≈ $31.56 Million |
0.272x | +7.98% |
| 2023-12-31 | ₩129.55 Billion ≈ $87.80 Million |
₩32.59 Billion ≈ $22.09 Million |
0.252x | +73.19% |
| 2022-12-31 | ₩106.07 Billion ≈ $71.88 Million |
₩15.41 Billion ≈ $10.44 Million |
0.145x | -31.15% |
| 2021-12-31 | ₩90.09 Billion ≈ $61.05 Million |
₩19.01 Billion ≈ $12.88 Million |
0.211x | +62.45% |
| 2020-12-31 | ₩71.95 Billion ≈ $48.76 Million |
₩9.34 Billion ≈ $6.33 Million |
0.130x | -44.91% |
| 2019-12-31 | ₩33.23 Billion ≈ $22.52 Million |
₩7.83 Billion ≈ $5.31 Million |
0.236x | +0.50% |
| 2018-12-31 | ₩27.24 Billion ≈ $18.46 Million |
₩6.39 Billion ≈ $4.33 Million |
0.235x | -- |
About T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more